Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations.
EXPeRT/PARTNER
adolescents and young adults
children
diagnosis
recommendations
salivary gland carcinoma
therapy
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
22
03
2021
received:
18
02
2021
accepted:
23
03
2021
entrez:
26
6
2021
pubmed:
27
6
2021
medline:
6
5
2022
Statut:
ppublish
Résumé
Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons generally follow adult guidelines. Complete surgical resection with adequate margins constitutes the cornerstone of treatment. However, the indications and modalities of adjuvant therapy remain controversial and may be challenging in view of the potential long-term toxicities in the pediatric population. This paper presents the consensus recommendations for the diagnosis and treatment of children and adolescents with SGCs, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER project (Paediatric Rare Tumours Network - European Registry).
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29058Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Sultan I, Rodriguez-Galindo C, Al-Sharabati S, Guzzo M, Casanova M, Ferrari A. Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases. Head Neck. 2011;33(10):1476-1481.
Yoshida EJ, García J, Eisele DW, Chen AM. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol. 2014;78(2):174-178.
Kattner P, Strobel H, Khoshnevis N, et al. Compare and contrast: pediatric cancer versus adult malignancies. Cancer Metastasis Rev. 2019;38(4):673-682.
Muenscher A, Diegel T, Jaehne M, Ussmüller J, Koops S, Sanchez-Hanke M. Benign and malignant salivary gland diseases in children. A retrospective study of 549 cases from the Salivary Gland Registry, Hamburg. Auris Nasus Larynx. 2009;36(3):326-331.
Shapiro NL, Bhattacharyya N. Clinical characteristics and survival for major salivary gland malignancies in children. Otolaryngol Head Neck Surg. 2006;134(4):631-634.
Gontarz M, Wyszyńska-Pawelec G, Zapała J. Primary epithelial salivary gland tumours in children and adolescents. Int J Oral Maxillofac Surg. 2018;47(1):11-15.
Xu B, Aneja A, Ghossein R, Katabi N. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome. Hum Pathol. 2017;67:37-44.
Morse E, Fujiwara RJT, Husain Z, Judson B, Mehra S. Pediatric salivary cancer: epidemiology, treatment trends, and association of treatment modality with survival. Otolaryngol Head Neck Surg. 2018;159(3):553-563.
Bradley P, McClelland L, Mehta D. Paediatric salivary gland epithelial neoplasms. ORL J Otorhinolaryngol Relat Spec. 2007;69(3):137-145.
Albeck H, Bentzen J, Ockelmann HH, Nielsen NH, Bretlau P, Hansen HS. Familial clusters of nasopharyngeal carcinoma and salivary gland carcinomas in Greenland natives. Cancer. 1993;72(1):196-200.
Merrick Y, Albeck H, Nielsen NH, Hansen HS. Familial clustering of salivary gland carcinoma in Greenland. Cancer. 1986;57(10):2097-2102.
Aro K, Klockars T, Leivo I, Mäkitie A. Familial predisposition for salivary gland cancer in Finland. Clin Med Insights Ear Nose Throat. 2014;7:7-11.
Delides A, Velegrakis G, Kontogeorgos G, Karagianni E, Nakas D, Helidonis E. Familial bilateral acinic cell carcinoma of the parotid synchronous with pituitary adenoma: case report. Head Neck. 2005;27(9):825-828.
Depowski PL, Setzen G, Chui A, Koltai PJ, Dollar J, Ross JS. Familial occurrence of acinic cell carcinoma of the parotid gland. Arch Pathol Lab Med. 1999;123(11):1118-1120.
Bradley PJ, Guntinas-Lichius O. Salivary Gland Disorders and Diseases: Diagnosis and Management. Stuttgart, Germany: Thieme; 2011:504.
Radoï L, Barul C, Menvielle G, et al. Risk factors for salivary gland cancers in France: results from a case-control study, the ICARE study. Oral Oncol. 2018;80:56-63.
Whatley WS, Thompson JW, Rao B. Salivary gland tumors in survivors of childhood cancer. Otolaryngol Head Neck Surg. 2006;134(3):385-388.
Schneider AB, Lubin J, Ron E, et al. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiat Res. 1998;149(6):625-630.
Boukheris H, Stovall M, Gilbert ES, et al. Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013;85(3):776-783.
Védrine PO, Coffinet L, Temam S, et al. Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasms. Head Neck. 2006;28(9):827-833.
Zamani M, Grønhøj C, Schmidt Jensen J, von Buchwald C, Charabi BW, Hjuler T. Survival and characteristics of pediatric salivary gland cancer: a systematic review and meta-analysis. Pediatr Blood Cancer. 2019;66(3):e27543.
Ribeiro KCB, Kowalski LP, Saba LMB, de Camargo B. Epithelial salivary glands neoplasms in children and adolescents: a forty-four-year experience. Med Pediatr Oncol. 2002;39(6):594-600.
Xu B, Katabi N. Evolving concepts and new entities in the 2017 WHO classification of salivary gland tumors. Diagn Histopathol. 2018;24(5):172-179.
Seethala RR, Stenman G. Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55-67.
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumours. IARC; 2017.
Kupferman ME, de la Garza GO, Santillan AA, et al. Outcomes of pediatric patients with malignancies of the major salivary glands. Ann Surg Oncol. 2010;17(12):3301-3307.
Aro K, Leivo I, Grénman R, Mäkitie AA. Paediatric salivary gland cancer in Finland. Int J Pediatr Otorhinolaryngol. 2012;76(9):1304-1307.
Fang QG, Shi S, Li ZN, Zhang X, Liu FY, Sun CF. Epithelial salivary gland tumors in children: a twenty-five-year experience of 122 patients. Int J Pediatr Otorhinolaryngol. 2013;77(8):1252-1254.
Cipriani NA, Lusardi JJ, McElherne J, et al. Mucoepidermoid carcinoma: a comparison of histologic grading systems and relationship to MAML2 rearrangement and prognosis. Am J Surg Pathol. 2019;43(7):885-897.
Thariat J, Vedrine PO, Orbach D, et al. Salivary gland tumors in children. Bull Cancer (Paris). 2011;98(7):847-855.
Thariat J, Vedrine PO, Temam S, et al. The role of radiation therapy in pediatric mucoepidermoid carcinomas of the salivary glands. J Pediatr. 2013;162(4):839-843.
Callender DL, Frankenthaler RA, Luna MA, Lee SS, Goepfert H. Salivary gland neoplasms in children. Arch Otolaryngol Head Neck Surg. 1992;118(5):472-476.
Wang X, Luo Y, Li M, Yan H, Sun M, Fan T. Management of salivary gland carcinomas - a review. Oncotarget. 2016;8(3):3946-3956.
Dykewicz CA, Centers for Disease Control and Prevention (U.S.), Infectious Diseases Society of America, American Society of Blood and Marrow Transplantation. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis. 2001;33(2):139-144.
Yu GY, Li ZL, Ma DQ, Zhang Y. Diagnosis and treatment of epithelial salivary gland tumours in children and adolescents. Br J Oral Maxillofac Surg. 2002;40(5):389-392.
Chiaravalli S, Guzzo M, Bisogno G, et al. Salivary gland carcinomas in children and adolescents: the Italian TREP project experience: salivary gland carcinoma in children. Pediatr Blood Cancer. 2014;61(11):1961-1968.
Rebours C, Couloigner V, Galmiche L, et al. Pediatric salivary gland carcinomas: diagnostic and therapeutic management: pediatric salivary gland carcinomas. Laryngoscope. 2017;127(1):140-147.
Feinstein AJ, Alonso J, Yang SE, St John M. Diagnostic accuracy of fine-needle aspiration for parotid and submandibular gland lesions. Otolaryngol Head Neck Surg. 2016;155(3):431-436.
Liu CC, Jethwa AR, Khariwala SS, Johnson J, Shin JJ. Sensitivity, specificity, and posttest probability of parotid fine-needle aspiration: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016;154(1):9-23.
Iro H, Zenk J. Salivary gland diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13:Doc06.
Zbären P, Triantafyllou A, Devaney KO, et al. Preoperative diagnostic of parotid gland neoplasms: fine-needle aspiration cytology or core needle biopsy? Eur Arch Otorhinolaryngol. 2018;275(11):2609-2613.
Kim HJ, Kim JS. Ultrasound-guided core needle biopsy in salivary glands: a meta-analysis. Laryngoscope. 2018;128(1):118-125.
Song IH, Song JS, Sung CO, et al. Accuracy of core needle biopsy versus fine needle aspiration cytology for diagnosing salivary gland tumors. J Pathol Transl Med. 2015;49(2):136-143.
Novoa E, Gürtler N, Arnoux A, Kraft M. Diagnostic value of core needle biopsy and fine-needle aspiration in salivary gland lesions. Head Neck. 2016;38(Suppl 1):E346-E352.
Kronz JD, Westra WH. The role of second opinion pathology in the management of lesions of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2005;13(2):81-84.
Skálová A, Stenman G, Simpson RHW, et al. The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol. 2018;42(2):e11-e27.
Drilon A, Laetsch TW, Kummar S, et al. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018;378(8):731-739.
Drilon A, Siena S, Ou SI, et al. Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov. 2017;7(4):400-409.
Guilmette J, Dias-Santagata D, Nosé V, Lennerz JK, Sadow PM. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol. 2019;83:50-58.
Salgado CM, Alaggio R, Reyes-Múgica M, Zin A, de Vito R. Clinicopathologic and molecular characterization of four cases of pediatric salivary secretory carcinoma (SSC), one with ETV6-RET fusion. Head Neck Pathol. 2021. https://doi.org/10.1007/s12105-021-01288-7
Yuan Y, Tang W, Tao X. Parotid gland lesions: separate and combined diagnostic value of conventional MRI, diffusion-weighted imaging and dynamic contrast-enhanced MRI. Br J Radiol. 2016;89(1060):20150912.
Thoeny HC. Imaging of salivary gland tumours. Cancer Imaging. 2007;7(1):52-62.
Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology. 2003;226(2):345-354.
Bertagna F, Nicolai P, Maroldi R, et al. Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: a systematic review. Rev Esp Med Nucl Imagen Mol. 2015;34(5):295-302.
Larson CR, Wiggins RH. FDG-PET imaging of salivary gland tumors. Semin Ultrasound CT MR. 2019;40(5):391-399.
Lee SH, Roh JL, Kim JS, et al. Detection of distant metastasis and prognostic prediction of recurrent salivary gland carcinomas using 18 F-FDG PET/CT. Oral Dis. 2018;24(6):940-947.
Park MJ, Oh JS, Roh JL, et al. 18F-FDG PET/CT versus contrast-enhanced CT for staging and prognostic prediction in patients with salivary gland carcinomas. Clin Nucl Med. 2017;42(3):e149-e156.
Westergaard-Nielsen M, Rohde M, Godballe C, et al. Up-front F18-FDG PET/CT in suspected salivary gland carcinoma. Ann Nucl Med. 2019;33(8):554-563.
Roh JL, Ryu CH, Choi SH, et al. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med. 2007;48(2):240-246.
Kim MJ, Kim JS, Roh JL, et al. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection. Ann Surg Oncol. 2013;20(3):899-905.
Almuhaimid TM, Lim WS, Roh JL, et al. Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma. J Cancer Res Clin Oncol. 2018;144(12):2485-2493.
Cheng NM, Hsieh CE, Liao CT, et al. Prognostic value of tumor heterogeneity and SUVmax of pretreatment 18F-FDG PET/CT for salivary gland carcinoma with high-risk histology. Clin Nucl Med. 2019;44(5):351-358.
Hsieh CE, Cheng NM, Chou WC, et al. Pretreatment primary tumor and nodal SUVmax values on 18F-FDG PET/CT images predict prognosis in patients with salivary gland carcinoma. Clin Nucl Med. 2018;43(12):869-879.
van Boxtel W, Lütje S, van Engen-van Grunsven ICH, et al. 68Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study. Theranostics. 2020;10(5):2273-2283.
Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell; 2016:272.
Brennan MT, Treister NS, Sollecito TP, et al. Dental disease before radiotherapy in patients with head and neck cancer: clinical registry of dental outcomes in head and neck cancer patients. J Am Dent Assoc. 2017;148(12):868-877.
Dahan LS, Giorgi R, Vergez S, et al. Mucoepidermoid carcinoma of salivary glands: a French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases. Eur J Surg Oncol. 2020;S0748-7983(20):31019.
Ryan JT, El-Naggar AK, Huh W, Hanna EY, Weber RS, Kupferman ME. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011;33(12):1769-1773.
Wang C, Mao M, Li B, Kim K, Han Z, Feng Z. Surgery alone is effective in the management of pediatric salivary gland acinic cell carcinoma. J Oral Maxillofac Surg. 2019;77(8):1713-1723.
Aro K, Leivo I, Mäkitie A. Management of salivary gland malignancies in the pediatric population. Curr Opin Otolaryngol Head Neck Surg. 2014;22(2):116-120.
Qureshi SS, Bhagat M, Singhal N, et al. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children. Head Neck. 2016;38(6):852-856.
Cockerill CC, Gross BC, Contag S, et al. Pediatric malignant salivary gland tumors: 60 year follow up. Int J Pediatr Otorhinolaryngol. 2016;88:1-6.
Galer C, Santillan AA, Chelius D, et al. Minor salivary gland malignancies in the pediatric population. Head Neck. 2012;34(11):1648-1651.
Orvidas LJ, Kasperbauer JL, Lewis JE, Olsen KD, Lesnick TG. Pediatric parotid masses. Arch Otolaryngol Head Neck Surg. 2000;126(2):177-184.
Rahbar R, Grimmer JF, Vargas SO, et al. Mucoepidermoid carcinoma of the parotid gland in children: a 10-year experience. Arch Otolaryngol Head Neck Surg. 2006;132(4):375-380.
Liu B, Liu JY, Zhang WF, Jia J. Pediatric parotid tumors: clinical review of 24 cases in a Chinese population. Int J Pediatr Otorhinolaryngol. 2012;76(7):1007-1011.
Laccourreye O, Werner A, Garcia D, Malinvaud D, Tran Ba Huy P, Bonfils P. First bite syndrome. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(5):269-273.
Hockstein NG, Samadi DS, Gendron K, Carpentieri D, Wetmore RF. Pediatric submandibular triangle masses: a fifteen-year experience. Head Neck. 2004;26(8):675-680.
Lin Y, Wang Y, Zhang H, August M, Xiang X, Zhang F. Sublingual gland tumors worldwide: a descriptive retrospective study of 839 cases. J Oral Maxillofac Surg. 2020;78(9):1546-1556.
Bradley PJ, Ferris RL. Surgery for malignant sublingual and minor salivary gland neoplasms. Adv Otorhinolaryngol. 2016;78:113-119.
Lee SY, Shin HA, Rho KJ, Chung HJ, Kim SH, Choi EC. Characteristics, management of the neck, and oncological outcomes of malignant minor salivary gland tumours in the oral and sinonasal regions. Br J Oral Maxillofac Surg. 2013;51(7):e142-e147.
Hay AJ, Migliacci J, Zanoni DK, McGill M, Patel S, Ganly I. Minor salivary gland tumors of the head and neck - Memorial Sloan Kettering experience. Incidence and outcomes by site and histological type. Cancer. 2019;125(19):3354-3366.
Rinaldo A, Shaha AR, Pellitteri PK, Bradley PJ, Ferlito A. Management of malignant sublingual salivary gland tumors. Oral Oncol. 2004;40(1):2-5.
Janot F, Baglin AC, Baujat B. Prise en charge des cancers ORL rares: synthèse des recommandations du réseau d'expertise français REFCOR. Oncologie. 2015;17(5):256-258.
Grant SR, Grosshans DR, Bilton SD, et al. Proton versus conventional radiotherapy for pediatric salivary gland tumors: acute toxicity and dosimetric characteristics. Radiother Oncol. 2015;116(2):309-315.
Chuong M, Bryant J, Hartsell W, et al. Minimal acute toxicity from proton beam therapy for major salivary gland cancer. Acta Oncol. 2020;59(2):196-200.
Mao M-H, Zheng L, Wang X-M, et al. Surgery combined with postoperative 125I seed brachytherapy for the treatment of mucoepidermoid carcinoma of the parotid gland in pediatric patients. Pediatr Blood Cancer. 2017;64(1):57-63.
Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol. 2006;24(17):2673-2678.
Cherifi F, Rambeau A, Johnson A, et al. [Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review]. Bull Cancer. 2019;106(10):923-938.